litlas
Log inCreate account

Thomas M. Coffman

Active 1985–2024

92
Papers
19,790
Citations
78
h-index
90
i10-index

Citations

Citations per year for Thomas M. Coffman1985: 1 citations1988: 1 citations1989: 1 citations1990: 2 citations1991: 5 citations1992: 4 citations1993: 1 citations1994: 3 citations1995: 7 citations1996: 28 citations1997: 34 citations1998: 64 citations1999: 58 citations2000: 115 citations2001: 150 citations2002: 143 citations2003: 169 citations2004: 159 citations2005: 165 citations2006: 198 citations2007: 209 citations2008: 205 citations2009: 174 citations2010: 231 citations2011: 257 citations2012: 204 citations2013: 180 citations2014: 199 citations2015: 164 citations2016: 129 citations2017: 142 citations2018: 109 citations2019: 395 citations2020: 573 citations2021: 522 citations2022: 433 citations2023: 286 citations2024: 468 citations2025: 232 citations2026: 2 citations1986–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,601 citing papers, 33.1% of this breakdownChina: 769 citing papers, 9.8% of this breakdownUnited Kingdom: 436 citing papers, 5.5% of this breakdownGermany: 404 citing papers, 5.1% of this breakdownJapan: 363 citing papers, 4.6% of this breakdownItaly: 309 citing papers, 3.9% of this breakdownCanada: 304 citing papers, 3.9% of this breakdownFrance: 234 citing papers, 3% of this breakdownAustralia: 223 citing papers, 2.8% of this breakdownBrazil: 162 citing papers, 2.1% of this breakdownSpain: 146 citing papers, 1.9% of this breakdownNetherlands: 130 citing papers, 1.6% of this breakdown
0%33.1%Other 22.7%

Institutions

Fields

  • Medicine64.3%
  • Biochemistry, Genetics and Molecular Biology20.5%
  • Immunology and Microbiology5.5%
  • Nursing4.5%
  • Neuroscience2.5%
  • Computer Science0.4%
  • Other2.3%

Topics

  • Renin-Angiotensin System Studies5%
  • Hormonal Regulation and Hypertension3.3%
  • Chronic Kidney Disease and Diabetes3%
  • Inflammatory mediators and NSAID effects2.8%
  • Receptor Mechanisms and Signaling2.3%
  • Eicosanoids and Hypertension Pharmacology1.9%
  • Other81.7%

Coauthors

All papers

Open in search
  1. Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology

    Authors: Steven J. Forrester, George W. Booz, Curt D. Sigmund, Thomas M. Coffman, Tatsuo Kawai, Victor Rizzo, Rosario Scalia, Satoru Eguchi - Physiological Reviews 2018 cited by 1,067

  2. Pathophysiology of Hypertension

    Authors: David G. Harrison, Thomas M. Coffman, Christopher S. Wilcox - Circulation Research 2021 cited by 339

  3. Mapping the genetic architecture of human traits to cell types in the kidney identifies mechanisms of disease and potential treatments

    Authors: Xin Sheng, Yuting Guan, Ziyuan Ma, Junnan Wu, Hongbo Liu, Chengxiang Qiu, Steven Vitale, Zhen Miao, Matthew J. Seasock, Matthew Palmer, Myung K. Shin, Kevin L. Duffin, Steven S. Pullen, Todd L. Edwards, Jacklyn N. Hellwege, Adriana M. Hung, Mingyao Li, Benjamin F. Voight, Thomas M. Coffman, Christopher D. Brown, Katalin Suszták - Nature Genetics 2021 cited by 164

  4. Animal Models of Hypertension: A Scientific Statement From the American Heart Association

    Authors: Lilach O. Lerman, Theodore W. Kurtz, Rhian M. Touyz, David H. Ellison, Alejandro Chade, Steven D. Crowley, David L. Mattson, John J. Mullins, Jeffrey L. Osborn, Alfonso Eirin, Jane F. Reckelhoff, Costantino Iadecola, Thomas M. Coffman - Hypertension 2019 cited by 310

  5. Artificial intelligence education: An evidence-based medicine approach for consumers, translators, and developers

    Authors: Faye Yu Ci Ng, Arun James Thirunavukarasu, Haoran Cheng, Ting Fang Tan, Laura Gutiérrez, Yanyan Lan, Jasmine Chiat Ling Ong, Yap Seng Chong, Kee Yuan Ngiam, Dean Ho, Tien Yin Wong, Kenneth Kwek, Finale Doshi‐Velez, Catherine R. Lucey, Thomas M. Coffman, Daniel Shu Wei Ting - Cell Reports Medicine 2023 cited by 106

  6. Abnormal lactate metabolism is linked to albuminuria and kidney injury in diabetic nephropathy

    Authors: Kengo Azushima, Jean‐Paul Kovalik, Takahiro Yamaji, Jianhong Ching, Tze Wei Chng, Jing Guo, Jianjun Liu, Mien T.X. Nguyen, Rashidah Binte Sakban, Simi Elizabeth George, Puay Hoon Tan, Su Chi Lim, Susan B. Gurley, Thomas M. Coffman - Kidney International 2023 cited by 66

  7. In the Wake of Systolic Blood Pressure Intervention Trial: New Targets for Improving Hypertension Management in Chronic Kidney Disease?

    Authors: Crystal C. Tyson, Thomas M. Coffman - ˜The œNephron journals/Nephron journals 2017 cited by 710

  8. Targeting endogenous kidney regeneration using anti-IL11 therapy in acute and chronic models of kidney disease

    Authors: Anissa A. Widjaja, Sivakumar Viswanathan, Shamini G. Shekeran, Eleonora Adami, Wei‐Wen Lim, Sonia Chothani, Jessie Tan, Joyce Wei Ting Goh, Huimei Chen, Sze Yun Lim, Carine M. Boustany‐Kari, Julie A. Hawkins, Enrico Petretto, Norbert Hübner, Sebastian Schäfer, Thomas M. Coffman, Stuart A. Cook - Nature Communications 2022 cited by 72

  9. Disruption of the Ang II type 1 receptor promotes longevity in mice

    Authors: Ariela Benigni, Daniela Corna, Carla Zoja, Aurelio Sonzogni, Roberto Latini, Monica Salio, Sara Conti, Daniela Rottoli, Lorena Longaretti, Paola Cassis, Marina Morigi, Thomas M. Coffman, Giuseppe Remuzzi - Journal of Clinical Investigation 2009 cited by 492

  10. Classical Renin‐Angiotensin System in Kidney Physiology

    Authors: Matthew A. Sparks, Steven D. Crowley, Susan B. Gurley, Maria Mirotsou, Thomas M. Coffman - Comprehensive physiology 2014 cited by 537

  11. Mouse Models of Diabetic Nephropathy

    Authors: Frank C. Brosius, Charles E. Alpers, Erwin P. Böttinger, Matthew D. Breyer, Thomas M. Coffman, Susan B. Gurley, Raymond C. Harris, Masao Kakoki, Matthias Kretzler, Edward H. Leiter, Moshe Levi, Richard McIndoe, Kumar Sharma, Oliver Smithies, Katalin Suszták, Nobuyuki Takahashi, Takamune Takahashi - Journal of the American Society of Nephrology 2009 cited by 888

  12. Modelling diabetic nephropathy in mice

    Authors: Kengo Azushima, Susan B. Gurley, Thomas M. Coffman - Nature Reviews Nephrology 2017 cited by 214

  13. Association of Diabetic Retinopathy and Diabetic Kidney Disease With All-Cause and Cardiovascular Mortality in a Multiethnic Asian Population

    Authors: Charumathi Sabanayagam, Miao Li Chee, Riswana Banu, Ching‐Yu Cheng, Su Chi Lim, E Shyong Tai, Thomas M. Coffman, Tien Yin Wong - JAMA Network Open 2019 cited by 118

  14. Oral Peroxisome Proliferator–Activated Receptor-α Agonist Enhances Corneal Nerve Regeneration in Patients With Type 2 Diabetes

    Authors: Calesta Hui Yi Teo, Molly Tzu-Yu Lin, Isabelle Xin Yu Lee, Siew-Kwan Koh, Lei Zhou, Dylan Shaoying Goh, Hyungwon Choi, Hiromi Wai Ling Koh, Amanda Yun Rui Lam, Paik Shia Lim, Jodhbir S. Mehta, Jean‐Paul Kovalik, Thomas M. Coffman, Hong Chang Tan, Yu‐Chi Liu - Diabetes 2022 cited by 40

  15. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney

    Authors: Steven D. Crowley, Susan B. Gurley, M Herrera, Phillip Ruiz, Robert Griffiths, A. Pradeep Kumar, Hyung‐Suk Kim, Oliver Smithies, Thu H. Le, Thomas M. Coffman - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 706

  16. Tubulovascular Cross-Talk by Vascular Endothelial Growth Factor A Maintains Peritubular Microvasculature in Kidney

    Authors: Henrik Dimke, Matthew A. Sparks, Benjamin R. Thomson, Sebastian Frische, Thomas M. Coffman, Susan E. Quaggin - Journal of the American Society of Nephrology 2014 cited by 172

  17. Cells of Renin Lineage Are Progenitors of Podocytes and Parietal Epithelial Cells in Experimental Glomerular Disease

    Authors: Jeffrey W. Pippin, Matthew A. Sparks, Sean T. Glenn, Sandra Buitrago, Thomas M. Coffman, Jeremy S. Duffield, Kenneth W. Gross, Stuart J. Shankland - American Journal Of Pathology 2013 cited by 154

  18. ACE and ACE2 Activity in Diabetic Mice

    Authors: Jan Wysocki, Minghao Ye, María José Soler, Susan B. Gurley, Hong Xiao, Kenneth E. Bernstein, Thomas M. Coffman, Sheldon Chen, Daniel Batlle - Diabetes 2006 cited by 339

  19. Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2

    Authors: Yan Cheng, Sandra Austin, Bianca Rocca, Beverly H. Koller, Thomas M. Coffman, Tilo Großer, John A. Lawson, Garret A. FitzGerald - Science 2002 cited by 791

  20. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes

    Authors: Stephen L. Tilley, Thomas M. Coffman, Beverly H. Koller - Journal of Clinical Investigation 2001 cited by 730

  21. Impact of genetic background on nephropathy in diabetic mice

    Authors: Susan B. Gurley, Sharon E. Clare, Kamie Snow, Ann Hu, Timothy W. Meyer, Thomas M. Coffman - American Journal of Physiology-Renal Physiology 2005 cited by 289

  22. The inextricable role of the kidney in hypertension

    Authors: Thomas M. Coffman - Journal of Clinical Investigation 2014 cited by 156

  23. Mouse Models of Diabetic Nephropathy

    Authors: Matthew D. Breyer, Erwin Böttinger, Frank C. Brosius, Thomas M. Coffman, Raymond C. Harris, Charles W. Heilig, Kumar Sharma - Journal of the American Society of Nephrology 2004 cited by 465

  24. Vascular Endothelial Growth Factor Receptor 2 Controls Blood Pressure by Regulating Nitric Oxide Synthase Expression

    Authors: Carie Facemire, Andrew B. Nixon, Robert Griffiths, Herbert I. Hurwitz, Thomas M. Coffman - Hypertension 2009 cited by 279